Patent details
EP2371391
Title:
Therapeutic use of anti-CS1 antibodies.
The time of generation of the report may vary depending on the number of the selected files and the pages of each file. If the generation of the consolidated PDF file takes long, you may reduce the number of selected files and proceed with the generation of the PDF in batches.
Ok
Cancel
You have not selected any documents
Ok
Basic Information
Publication number:
EP2371391
WO Application Number:
Type:
European Patent Granted for NL
Status:
Expired. Art. 36.6 ROW
Publication Title:
Title When Made Available For Viewing:
Reason Lapsed:
Application number:
EP10183377.0
WO Publication Number:
EPO Publication Language:
English
SPC Number:
300838
First Applicant Residence Country:
United States of America (US)
Publications:
Dates
Filing date:
10/05/2004
Grant date:
23/07/2014
EP Publication Date:
23/07/2014
WO Publication Date:
Claims Translations Received Date:
Claims Translation B1 Received Date:
Claims Translation B2 Received Date:
Claims Translation B3 Received Date:
Lapsed By Non Payment Annual Fee Date:
Renunciation Date:
NullificationDate:
Published:
Due To Cession Date:
Registration date:
23/07/2014
EP B1 Publication Date:
23/07/2014
EP B2 Publication Date:
EP B3 Publication Date:
Description Translation B1 Received Date:
22/10/2014
Description Translation B2 Received Date:
Description Translation B3 Received Date:
Expiration date:
09/05/2024
Lapsed By Expiration Date:
10/05/2024
Revocation Date:
Invalidity Date:
Response To Novelty Search Report Received:
Patent Granting Request:
Lapsed date:
Applicant/holder
From:
23/07/2014
Name:
AbbVie Biotherapeutics Inc.
Address:
1500 Seaport Boulevard, REDWOOD CITY, CA 94063, United States of America (US)
Domicile Holder
Name:
ir. J.C. Volmer c.s.
From:
23/07/2014
Address:
Exter Polak & Charlouis B.V.
Postbus 3241, 2280 GE, Rijswijk, Netherlands (NL)
To:
Inventor
1
Name:
Williams, Marna
Address:
PALO ALTO, CA 94306, United States of America (US)
2
Name:
Tso, Yun J.
Address:
MENLO PARK, CA 94025, United States of America (US)
3
Name:
Landolfi, Nicolas F.
Address:
PALO ALTO, CA 94025, United States of America (US)
4
Name:
Liu, Gao
Address:
MOUNTAIN VIEW, CA 94040, United States of America (US)
5
Name:
Powers, David B.
Address:
FAIRFAX, CA 94930, United States of America (US)
Priority
1
Priority Patent Number:
557620 P
Priority Date:
29/03/2004
Priority Country:
United States of America (US)
2
Priority Patent Number:
557621 P
Priority Date:
29/03/2004
Priority Country:
United States of America (US)
3
Priority Patent Number:
557622 P
Priority Date:
29/03/2004
Priority Country:
United States of America (US)
4
Priority Patent Number:
469211 P
Priority Date:
08/05/2003
Priority Country:
United States of America (US)
Classification
Main IPC Class:
A61K 39/395 ;
IPC or IDT classification:
A61P 35/00 ;
A61P 37/00 ;
C07K 14/705 ;
C07K 16/28 ;
C12N 5/20 ;
Publication
Bulletin
1
Bulletin Heading:
VRV
Journal edition number:
20/24
Publication date:
15/05/2024
Description:
Lapse or annulment
2
Bulletin Heading:
EP3
Journal edition number:
2014/48
Publication date:
26/11/2014
Description:
European patents granted for the Netherlands in which a translation was filed ex Article 52 par. 1 of the NL Patent Law 1995
3
Bulletin Heading:
EP2
Journal edition number:
2014/31
Publication date:
30/07/2014
Description:
European patents granted for the Netherlands
European Patent Bulletin
Issue number:
201430
Publication date:
23/07/2014
Description:
Grant (B1)
Annual Fee
Annual Fee(s) Due Date:
Annual Fee Number:
Last Annual Payment Date:
17/04/2023
Last Annual Fee Paid Number:
20
Last Annual Fee Paid Amount:
1400 Euro
Payer:
Master Data Center
Filing date
Document type
Document Description
Number of pages
File Type
18/11/2014
Outgoing Correspondence
Outgoing Letter
1
PDF
/7/7/3/3/8/0510183377/docs/ep10183377.0_2_outgoingcorrespondence20141118.pdf
22/10/2014
Incoming Correspondence Paper
Accompanying letter incoming document
2
PDF
/7/7/3/3/8/0510183377/docs/ep10183377.0_0_incomingcorrespondencepaper20141022.pdf
22/10/2014
Claims
Translated claims
3
PDF
/7/7/3/3/8/0510183377/docs/ep10183377.0_1_claims20141022.pdf
22/10/2014
Outgoing Correspondence
Outgoing Letter
1
PDF
/7/7/3/3/8/0510183377/docs/ep10183377.0_3_outgoingcorrespondence20141022.pdf